Q1 2017 13F Holders as of 3/31/2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
105M
-
Number of holders
-
564
-
Total 13F shares, excl. options
-
71.5M
-
Shares change
-
+6.32M
-
Total reported value, excl. options
-
$27.7B
-
Value change
-
+$2.46B
-
Put/Call ratio
-
1.02
-
Number of buys
-
280
-
Number of sells
-
-249
-
Price
-
$387.51
Significant Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q1 2017
683 filings reported holding REGN - REGENERON PHARMACEUTICALS, INC. - COMMON STOCK as of Q1 2017.
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) has 564 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 71.5M shares
of 105M outstanding shares and own 68.08% of the company stock.
Largest 10 shareholders include Capital World Investors (7.09M shares), FMR LLC (6.62M shares), BlackRock Inc. (6.15M shares), WELLINGTON MANAGEMENT GROUP LLP (6.14M shares), VANGUARD GROUP INC (5.12M shares), STATE STREET CORP (3.38M shares), SANDS CAPITAL MANAGEMENT, LLC (2.93M shares), Artisan Partners Limited Partnership (1.93M shares), LOOMIS SAYLES & CO L P (1.72M shares), and POLEN CAPITAL MANAGEMENT LLC (1.48M shares).
This table shows the top 564 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.